
PDRN microneedle patches
A focused ritual for the eye contour.
A little care for the days that show around your eyes. Meet our crescent-shaped PDRN patch, designed around a soft, unhurried eye-care ritual. PDRN is not a peptide, and this product does not carry the peptide story.
Join early accessComing soon. Join us for a first look at launch.
The product images show the current patch design. An eye-contour ritual is the cosmetic intention here. Final benefit wording will depend on the finished formulation and its supporting evidence.
A focus on the feeling of replenished skin.
A cosmetic direction for smoother-looking skin.
A considered approach to skin comfort.
An intended focus on supple-looking skin.
The sample labels include these benefit themes. Product-specific substantiation has not yet been supplied.

PDRN is short for polydeoxyribonucleotide. It is not a peptide, and this product does not carry the peptide story. The PDRN name is not a substitute for the full ingredient list. This product does not contain the two-step system's peptide stages.
The material visuals on this page are illustrative. They do not show measured delivery, a clinical result, or the exact microscopic construction of the sample.
Explore ingredientsStart with clean, dry skin in the intended area.
Place on the targeted area, following the label.
Leave on for 100 minutes, then remove.
These are the supplied sample directions. Read the instructions on your specific product. Wear time starts at 100 minutes. A four-hour wear and an overnight wear are also options.
Longer wear is not described here as more effective. That has not been established for these samples.
Discover the ritualFor external use only. Store in a cool, dry place and away from sunlight. Keep any expiry and additional handling instructions with the product so they are easy to consult.
The sample batch field belongs to product identification. If you have a question, include the product name and the batch reference if available.
Product enquiriesFinal formulation, supported claims, and launch availability remain subject to development and verification. Quality updates will be shared through early access.
Our quality commitment